Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
সব দামের পরিবর্তন →Save on this medicine
Same active ingredient — pay up to 72% less
These brands contain the same active ingredient (Amiodarone Hydrochloride). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
Cordarone এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Tablet: The usual dose is 200 mg 3 times daily for 1 week, then reduced to 200 mg twice daily, or the minimum dose needed to control the arrhythmia. Amiodarone is usually given in several doses through the day to minimize the stomach upset that is seen more often with higher doses. For this same reason, it is also recommended that Amiodarone be taken with meals. Injection: The recommended starting dose is about 1000 mg over the first 24 hours of therapy, given by the following infusion regimen. First, an initial load of 150 mg per 100 mL (in D5W or Normal Saline) is infused over 10 minutes. This is followed by an infusion of 1 mg per minute for 6 hours, followed by 0.5 mg per minute after that. If breakthrough episodes of VF or hemodynamically unstable VT occur, the initial load described above should be repeated as needed, infused over 10 minutes, and the rate of the maintenance infusion increased to achieve effective suppression of the arrhythmia.
পার্শ্বপ্রতিক্রিয়া
The most serious risks with Cardiron therapy involve the lungs, and these reactions can be fatal. Patients should tell their doctor if they notice cough, fever, or painful breathing. Though rare, fatal liver toxicity has also been reported with Cardiron therapy. Other reported effects include reversible corneal microdeposits, sometimes accompanied by night glare; rarely, impaired vision from optic neuritis; peripheral neuropathy and myopathy, usually reversible after stopping treatment; slow heart rate and conduction disturbances; sensitivity to sunlight and, rarely, lasting skin discolouration; underactive or overactive thyroid; raised liver enzymes; and jaundice, hepatitis, or cirrhosis. Less common complaints include nausea, vomiting, a metallic taste, tremor, sweating, dizziness, headache, sleeplessness, fatigue, hair loss, benign raised pressure in the skull, unsteady movement, rashes, vasculitis, kidney involvement, low platelet count, and haemolytic or aplastic anaemia. Depending on severity, the dose of Cardiron may be reduced, or treatment may need to be stopped altogether.
সতর্কতা ও নিষেধাজ্ঞা
নিষেধাজ্ঞা
Amiodarone should not be used in patients with cardiogenic shock; severe sinus-node dysfunction that causes marked sinus bradycardia; second- or third-degree atrioventricular block; or a history of bradycardia-induced syncope (unless a pacemaker is fitted). It is also contraindicated in anyone with known hypersensitivity to amiodarone or to any of its components, including iodine.